July 24, 2026 · Form 4 insider transaction
Madaus Martin D bought 2,538 shares of Haemonetics Corporation, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.; Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.